TARA FISHER: Open Payments
NPI 1699091975 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,164 in 115 payments from 23 companies in 2025. Trend: 2023 $2,070 · 2024 $2,617 · 2025 $2,164
Food & beverage: $2,164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $432 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $216 |
| AstraZeneca Pharmaceuticals LP | 6 | $192 |
| Lilly USA, LLC | 13 | $177 |
| PFIZER INC. | 13 | $168 |
| Novo Nordisk Inc | 11 | $165 |
| Otsuka America Pharmaceutical, Inc. | 2 | $143 |
| Axsome Therapeutics, Inc. | 5 | $140 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
Products named: VRAYLAR, Kerendia, MOUNJARO, UBRELVY, Auvelity, AIRSUPRA, ABILIFY MAINTENA, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
